Search
Feedback
About UniCat 
Help
News
Book
Year: 1946 Publisher: Paris: Flammarion,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1954 Publisher: Paris: Flammarion,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
ISBN: 082478121X 9780824781217 Year: 2000 Publisher: New York: Dekker,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 2009 Publisher: Bruxelles: UCL,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Tuberculosis is a contagious disease that spreads through the air. According to recent estimates by the World Health Organization approximately 1.77 million people died of TB in 2007 around the world (WHO, 2007).
The outline of tuberculosis treatment did not change during the last three decades: it is based mostly on a quadrithérapie for two months (isoniazid, rifampicin, pyrazinamide and ethambutol) followed by dual for four months ( isoniazid, rifampicin).
Considering the increase of multidrug resistance, in addition to usual antituberculosis drugs, there are several alternatives that have demonstrated their effectiveness (linezolid and some quinolones).
Otherwise, there are molecules in phase two and three of clinical trials with a different mode of action compared to existing molecules (R207910). La tuberculose est une maladie contagieuse qui se propage par voie aérienne. Selon les estimations récentes de l’organisation mondiale de la santé environ 1.77 millions de personnes sont mortes de la tuberculose en 2007 à travers le monde (WHO, 2007).
Les grandes lignes du traitement de la tuberculose n'ont pas changé au cours des trois dernières décennies : celui-ci repose le plus souvent sur une quadrithérapie pendant deux mois (isoniazide, rifampicine, pyrazinamide et éthambutol) relayée par une bithérapie pendant quatre mois (isoniazide, rifampicine).
Vu la progression de la multiresistance, outre des antituberculeux usuels, on dispose actuellement plusieurs alternatives ayant démontrés leur efficacité (Linezolide et certains quinolones).
A part cela, il existe des molécules en phase deux et trois des essais thérapeutiques ayant une mode d’action différentes par rapport aux molécules existantes (R207910).
Dissertation
Year: 1821 Publisher: A Paris : de l'imprimerie de Didot le jeune,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1852 Publisher: Gand : Gyselynck,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Dissertation
Year: 1943 Publisher: Lyon : Bosc frères,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1843 Publisher: Paris : J. B. Baillière,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)
Book
Year: 1949 Publisher: Paris : Presses universitaires de France,
Abstract | Keywords | Export | Availability | Bookmark
Loading...Choose an application
- Reference Manager
- EndNote
- RefWorks (Direct export to RefWorks)